[1]
“Linking inflammation and cardiovascular disease: the emerging role of lipoprotein-associated phosphoplipase A2”, UJC, vol. 32, no. 6, pp. 41–49, Dec. 2025, doi: 10.31928/2664-4479-2025.6.4149.